Dose‐dense adjuvant chemotherapy in HER2‐positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial
暂无分享，去创建一个
M. Ceppi | F. Puglisi | O. Garrone | F. Montemurro | F. Cognetti | E. de Azambuja | A. Fabi | M. De Laurentiis | M. Lambertini | F. Poggio | L. Del Mastro | G. Bisagni | M. Giuliano | A. Durando | C. Bighin | B. Conte | M. Bruzzone | A. Turletti | Y. Urracci